关注
Apostolos Tsapas
Apostolos Tsapas
Professor of Medicine and Diabetes, Aristotle University Thessaloniki
在 auth.gr 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes
B Zinman, C Wanner, JM Lachin, D Fitchett, E Bluhmki, S Hantel, ...
New england journal of medicine 373 (22), 2117-2128, 2015
123922015
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the …
SE Inzucchi, RM Bergenstal, JB Buse, M Diamant, E Ferrannini, M Nauck, ...
Diabetologia 55 (6), 1577-1596, 2012
67422012
Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
MJ Davies, DA D’Alessio, J Fradkin, WN Kernan, C Mathieu, G Mingrone, ...
Diabetes care 41 (12), 2669-2701, 2018
41942018
Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European …
SE Inzucchi, RM Bergenstal, JB Buse, M Diamant, E Ferrannini, M Nauck, ...
Diabetes care 38 (1), 140-149, 2015
36742015
2019 update to: management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study …
JB Buse, DJ Wexler, A Tsapas, P Rossing, G Mingrone, C Mathieu, ...
Diabetes care 43 (2), 487-493, 2020
18112020
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
AF Hernandez, JB Green, S Janmohamed, RB D'Agostino, CB Granger, ...
The Lancet 392 (10157), 1519-1529, 2018
13652018
Sodium–glucose cotransporter 2 inhibitors for type 2 diabetes: a systematic review and meta-analysis
D Vasilakou, T Karagiannis, E Athanasiadou, M Mainou, A Liakos, ...
Annals of internal medicine 159 (4), 262-274, 2013
11432013
Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European …
SE Inzucchi, RM Bergenstal, JB Buse, M Diamant, E Ferrannini, M Nauck, ...
Diabetologia 58 (3), 429-442, 2015
9142015
American Diabetes Association (ADA); European Association for the Study of Diabetes (EASD). Management of hyperglycemia in type 2 diabetes: a patient-centered approach …
SE Inzucchi, RM Bergenstal, JB Buse, M Diamant, E Ferrannini, M Nauck, ...
Diabetes care 35 (6), 1364-1379, 2012
8402012
Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
MJ Davies, VR Aroda, BS Collins, RA Gabbay, J Green, NM Maruthur, ...
Diabetes care 45 (11), 2753-2786, 2022
7162022
Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis
T Karagiannis, P Paschos, K Paletas, DR Matthews, A Tsapas
Bmj 344, 2012
5892012
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
MJ Davies, VR Aroda, BS Collins, RA Gabbay, J Green, NM Maruthur, ...
Diabetologia 65 (12), 1925-1966, 2022
4572022
Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis
E Bekiari, K Kitsios, H Thabit, M Tauschmann, E Athanasiadou, ...
bmj 361, 2018
4422018
The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related …
VG Athyros, TK Alexandrides, H Bilianou, E Cholongitas, M Doumas, ...
Metabolism 71, 17-32, 2017
2912017
Comparative effectiveness of glucose-lowering drugs for type 2 diabetes: a systematic review and network meta-analysis
A Tsapas, I Avgerinos, T Karagiannis, K Malandris, A Manolopoulos, ...
Annals of internal medicine 173 (4), 278-286, 2020
2662020
Efficacy and safety of empagliflozin for type 2 diabetes: a systematic review and meta‐analysis
A Liakos, T Karagiannis, E Athanasiadou, M Sarigianni, M Mainou, ...
Diabetes, Obesity and Metabolism 16 (10), 984-993, 2014
2552014
Preferred reporting items for overviews of systematic reviews including harms checklist: a pilot tool to be used for balanced reporting of benefits and harms
KI Bougioukas, A Liakos, A Tsapas, E Ntzani, AB Haidich
Journal of clinical epidemiology 93, 9-24, 2018
2252018
Pharmacologic interventions for painful diabetic neuropathy: an umbrella systematic review and comparative effectiveness network meta-analysis
ML Griebeler, OL Morey-Vargas, JP Brito, A Tsapas, Z Wang, ...
Annals of internal medicine 161 (9), 639-649, 2014
2182014
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
PA Sarafidis, A Tsapas
J Med 373, 2117-2128, 2015
2122015
A systematic review and meta-analysis of tests to predict wound healing in diabetic foot
Z Wang, R Hasan, B Firwana, T Elraiyah, A Tsapas, L Prokop, JL Mills Sr, ...
Journal of vascular surgery 63 (2), 29S-36S. e2, 2016
1672016
系统目前无法执行此操作,请稍后再试。
文章 1–20